Fennec Pharmaceuticals Inc Q4 Loss Decreases, Beats Estimates

(RTTNews) - Fennec Pharmaceuticals Inc (FENC) released Loss for fourth quarter that decreased from last year and beat the Street estimates.

The company's earnings totaled -$1.62 million, or -$0.06 per share. This compares with -$2.68 million, or -$0.10 per share, last year.

Analysts on average had expected the company to earn -$0.13 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period fell 18.6% to $7.93 million from $9.74 million last year.

Fennec Pharmaceuticals Inc earnings at a glance (GAAP) :

-Earnings: -$1.62 Mln. vs. -$2.68 Mln. last year. -EPS: -$0.06 vs. -$0.10 last year. -Revenue: $7.93 Mln vs. $9.74 Mln last year.